Stock listing
Marvel Biosciences Corp
Selected listing: MRVL · TSXV · CAD · CA
Marvel Biosciences Corp (TSXV:MRVL), Health Technology. Latest release Oct 6, 2026: Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial…
- Ticker
- TSXV:MRVL
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSXV
- Currency
- CAD
About Marvel Biosciences Corp
Marvel Biosciences Corp (MRVL) is a public company based in Canada, focused on developing innovative therapies in the biosciences sector. Investors can find information about its operations, goals, and market performance on its public company page.
Latest news from Marvel Biosciences Corp
Marvel Biosciences Signs Letter of Intent with Novatech for Phase 1 Trial of MB-204 and Provides Corporate Update
October 6, 2026
Marvel Biosciences Announces Closing of Private Placement For Up To $3.0 Million
September 29, 2026
Marvel Biosciences Provides Update on Private Placement for up to $3.0 Million
September 17, 2026
Marvel Biosciences Announces Extension to Closing Date of Private Placement
September 9, 2026
Marvel Biosciences Expands Private Placement to Quebec
August 19, 2026
Research Marvel Biosciences Corp
Marvel Biosciences Corp company profile
View the public company page for Marvel Biosciences Corp on 6ix.
Marvel Biosciences Corp news
Read company news and market updates connected to Marvel Biosciences Corp.
Marvel Biosciences Corp investor events
Find investor webinars, events, and replay context for Marvel Biosciences Corp.